Pricing and sales strategy
Sell SCRIMED as a governed healthcare intelligence operating layer, not a generic AI tool.
The recommended commercial model starts with public product preview, moves qualified buyers into paid assessments and synthetic pilots, then expands into protected pilots, annual enterprise licenses, and strategic platform partnerships.
Recommended model
Hybrid enterprise model: free public preview, paid assessment, paid synthetic pilot, protected enterprise pilot, annual platform license, and custom strategic partnerships.
SCRIMED pricing and sales motions currently sell governed synthetic evaluations, readiness assessments, and protected enterprise pilots. Pricing does not imply live clinical execution, autonomous diagnosis, payer submission, reimbursement guarantees, or production medical-record processing.
01Official Wix website: Brand discovery, credibility, founder story, high-level product education, and public contact capture.02Vercel app subdomain: Product console, AgentOS evaluation, pilot intake, pricing, trust, workflows, and enterprise proof stack.03Product Console: Inspect sellable offers, workflow examples, proof stack, governance controls, and readiness brief.04AgentOS Evaluation Workspace: Run a synthetic workflow packet through AgentOS and Atlas Trust Cards before a sales call.05Pilot Intake: Request an assessment, synthetic pilot, governance audit, or automation blueprint.
Pricing tiers
Start with paid evaluation value, then expand through governed enterprise deployment.
public-preview
Public Product Preview
Website visitors, investors, advisors, and early enterprise evaluators
Free public access
- Qualified buyer moves from education to pilot intake.
- Expansion: Synthetic Pilot Evaluation
- Public preview is a product education surface, not a live clinical system.
sellable-now
Workflow Intelligence Assessment
Hospitals, clinics, payers, and transformation teams validating workflow opportunity before a pilot
Recommended range: $15k-$35k fixed fee
- Buyer approves pilot scope, value hypothesis, and governance gates.
- Expansion: Synthetic Pilot Evaluation or AI Readiness + Governance Audit
- Assessment produces operational intelligence for human leaders; it is not clinical advice.
sellable-now
Synthetic Pilot Evaluation
Enterprise buyers who want to evaluate SCRIMED against synthetic workflows before live integration
Recommended range: $35k-$95k for 30-90 days
- Buyer validates workflow value, trust posture, and protected-pilot business case.
- Expansion: Protected Enterprise Pilot
- Synthetic data only; no diagnosis, treatment, payer submission, or patient outreach.
protected-pilot
Protected Enterprise Pilot
Health systems, payers, public-sector programs, and enterprise operators preparing controlled deployment
Recommended range: $150k-$400k for 90-180 days
- Buyer approves annual operating license, connector scope, and governed production plan.
- Expansion: Enterprise Operating License
- Protected pilot still requires human review and approved controls before any live clinical workflow use.
enterprise-license
Enterprise Operating License
Large hospitals, payers, government health agencies, and multi-site healthcare organizations
Annual license: custom, recommended floor $300k+
- Multi-workflow expansion with measurable operational value and governed trust posture.
- Expansion: Strategic Platform Partnership
- Production use requires signed controls, approved workflows, and human-review operating procedures.
strategic
Strategic Platform Partnership
Governments, national health systems, major payers, strategic hospital networks, and global partners
Custom multi-year partnership
- SCRIMED becomes a governed healthcare intelligence infrastructure partner.
- Expansion: Regional or ecosystem-level deployment
- Strategic work remains governed, auditable, human-reviewed, and regionally compliant.
Sales motion
Move buyers from website interest to governed enterprise commitment.
Website to Product
Buyer learns the brand on Wix and clicks into the SCRIMED product app.
- Route buyer to Product Console, Pricing, Evaluation, or Pilot Intake.
- Buyer has healthcare workflow, governance, interoperability, or AI readiness need.
- Run evaluation or submit pilot intake.
Self-Guided Product Evaluation
Buyer inspects synthetic AgentOS/Atlas outputs without needing Vercel or an account.
- Package product proof around task plans, Trust Cards, audit preview, and observability.
- Buyer confirms one or more high-value workflows and a sponsor.
- Paid assessment or synthetic pilot.
Paid Evaluation or Synthetic Pilot
Buyer requests scoped assessment or pilot and acknowledges no-PHI boundary.
- Qualify buyer, define scope, metrics, governance gates, and decision criteria.
- Sponsor, budget range, workflow owner, review team, and pilot success metrics exist.
- Protected pilot or annual license proposal.
Protected Pilot to Enterprise License
Buyer reviews implementation, security, compliance, and annual operating model.
- Propose base platform license plus workflow, connector, agent, support, and usage scope.
- BAA, identity, audit, connector, security, and human-review controls approved.
- Annual enterprise agreement.
Enterprise Expansion
Buyer expands from one workflow to multiple departments, regions, or organizations.
- Use observability, trust metrics, and governance reporting to support expansion.
- Measured value and safety posture remain strong under review.
- Multi-year strategic partnership.
Value metrics
Price against workflow value, governance scope, and deployment complexity.
metric
Workflows under governance
Healthcare buyers buy workflow transformation, not generic AI usage.
Primary enterprise package metric for pilots and annual licenses.
- Workflow expansion requires approved human-review and audit controls.
metric
Agent and service modules enabled
Sanar AI, DocuTwin, CareExplain, Ambient Scribe, TrialCore, PayerIQ, and future services carry different value and risk.
Module add-ons and tier expansion.
- No module implies autonomous diagnosis, treatment, payer submission, or patient outreach.
metric
Connector and integration scope
EHR, payer, CRM, knowledge, and analytics connectors drive implementation cost and enterprise value.
Implementation and annual support scope.
- Live connectors require BAA, tenant identity, audit, security, and approval controls.
metric
Evaluation and task volume
AI-heavy usage should scale with actual activity without surprising buyers.
Usage band or credit pool after pilot validation.
- Usage pricing should be capped or contracted to preserve buyer trust.
metric
Organizations, regions, and departments
SCRIMED can expand from department workflow to enterprise operating layer.
Enterprise and strategic partnership expansion.
- Regional compliance, data residency, language, and governance needs must be explicit.
Commercial guardrails
Sales should increase trust, not create clinical or regulatory overclaim risk.
Do not publish low consumer-style pricing
SCRIMED is an enterprise healthcare operating layer. Public pricing should show package ranges or 'starts at' for evaluations, with enterprise pilots handled by sales.
Sell outcomes as measured pilot signals
Use time saved, workflow friction, denial risk, access bottlenecks, documentation quality, and trust completeness as pilot metrics, not unsupported clinical claims.
Separate public preview from paid pilots
Website visitors can inspect the product, but paid assessments and pilots require sponsor, workflow scope, governance needs, and no-PHI acknowledgement.
Keep medical-device and clinical claims out of sales copy
SCRIMED should present as governed operational intelligence until clinical, regulatory, and production execution controls are explicitly approved.
Use enterprise sales with sales engineering
Healthcare buyers need security, compliance, workflow, interoperability, ROI, and trust review before annual license commitment.